1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)

Requip Relieves Restless Legs

Last updated on: November 14, 2020

Significant improvement found in patients with RLS.

Requip Relieves Restless LegsThe first double-blind, placebo-controlled study of Requip in patients with restless legs syndrome (RLS) showed the drug led to significant improvement in the periodic leg movements (PLMS) of sleep. The primary outcome measure was to determine whether the number of leg movements per hour in NREM sleep was reduced in patients treated with Requip vs. placebo-treated patients. Patients with primary RLS (n=31) were started on 0.25 mg/dose of Requip administered in the evening, and then maintained at that dosage for 2 weeks. The dose of Requip ranged from 0.25 to 6 mg/day with an average of 1.7 mg/day.

Leave a Reply
Notify of